Sotera Health (SHC)
12.74
-0.35 (-2.67%)
At close: Jan 14, 2025, 3:59 PM
12.76
0.12%
After-hours Jan 14, 2025, 04:00 PM EST
undefined% (undefined)
| Bid | 5.14 |
| Market Cap | 3.61B |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | 0.25 |
| PE Ratio (ttm) | 50.98 |
| Forward PE | n/a |
| Analyst | Buy |
| Ask | 14.4 |
| Volume | 863,139 |
| Avg. Volume (20D) | 1,214,293 |
| Open | 13.03 |
| Previous Close | 13.09 |
| Day's Range | 12.63 - 13.11 |
| 52-Week Range | 10.71 - 17.44 |
| Beta | undefined |
About SHC
Sotera Health Company provides sterilization, and lab testing and advisory services in the United States, Canada, Europe, and internationally. The company's sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medical device and biopharmaceutical industries. It serves medical devices; pharmaceuticals; food and agricul...
Industry Medical - Diagnostics & Research
Sector Healthcare
IPO Date Nov 20, 2020
Employees 3,000
Stock Exchange NASDAQ
Ticker Symbol SHC
Website https://soterahealth.com
Analyst Forecast
According to 6 analyst ratings, the average rating for SHC stock is "Buy." The 12-month stock price forecast is $17, which is an increase of 33.39% from the latest price.
Buy 66.67%
Hold 33.33%
Sell 0.00%
Next Earnings Release
Sotera Health is scheduled to release its earnings on Feb 25, 2025,
before market opens.
Analysts project revenue of $301.81M, reflecting a -2.72% YoY shrinking and earnings per share of 0.22, making a -15.38% decrease YoY.
Analysts project revenue of $301.81M, reflecting a -2.72% YoY shrinking and earnings per share of 0.22, making a -15.38% decrease YoY.
4 months ago ·
Source
+6.94%
Sotera Health shares are trading higher. The compa...
Unlock content with
Pro Subscription
5 months ago ·
Source
+7.56%
Sotera Health shares are trading higher after the company reported strong Q2 results.
